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Abstract 
Background/Aims: Following an incident involving toxic chemicals, deployment of 
countermeasures before the arrival of specialised services at the scene may provide a  
“therapeutic” window in which to mitigate skin absorption. Methods: Five potential 
candidates (itaconic acid, N,N′-methylenebisacrylamide, 2-trifluoromethylacrylic acid, fuller’s 
earth and Fast-Act®) previously found effective against a simulant (methyl salicylate) were 
evaluated against a 10 µL droplet of 14C-sulphur mustard (HD), soman (GD) or VX applied to 
the surface of porcine skin mounted on static skin diffusion cells. Results: All the 
decontaminants applied to the skin 5 minutes post exposure achieved a marked reduction in 
the amount of 14C contaminant remaining within the skin at 24 hours. Itaconic acid 
significantly (p<0.05) reduced the amount of 14C-HD, GD and VX remaining in the skin at 24 
hours. Additionally, 2-trifluoromethylacrylic acid significantly reduced the amount of 14C-HD, 
whilst fuller’s earth significantly reduced the amounts of 14C-HD and VX recovered within the 
skin at 24 hours. Conclusion: All of the products evaluated in this study performed well in 
reducing the dermal absorption of all the chemical warfare agents tested.  
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1. Introduction 
Decontamination can be defined as “the process of removing hazardous material(s) both 
on or available to the external surfaces of the body in order to reduce local or systemic 
exposure to a contaminant and thus minimise the risk of subsequent adverse health effects” 
(Chilcott, 2014). It is well established that a major route of exposure to chemical warfare 
(CW) agents is via contact with the skin (Evison, 2002). The deliberate release of chemical 
warfare agents targeting civilian populations, exemplified by the sarin attacks in Tokyo 
(1995) and Syria (2014) (Eisenkraft, 2014; Okumura, 1996), has led to the continued 
development of more effective decontamination strategies focused on dealing with civilian 
mass-casualty incidents (Amlot, 2010; Amlôt, 2017; Kassouf, 2017; Matar, 2016). 
Typically, decontamination strategies include physical removal or chemical 
neutralisation. Physical removal methodologies aim to remove contaminants, whereas 
chemical neutralisation aims to modify the structure of the contaminant in order to reduce or 
eliminate toxicity by hydrolysis, oxidation or metabolism (Chan, 2013). The issue 
surrounding chemical neutralising agents is the lack of a single substance capable of 
neutralising compounds with a wide range of physiochemical properties and a potential for 
skin or eye irritation. Furthermore, it has been demonstrated that some neutralising products 
(e.g. bioscavengers) undergo stoichiometric reactions that result in rapid saturation (Nachon, 
2013). In certain cases, there is the potential to inadvertently produce toxic breakdown 
products, as observed with the degradation of VX (Munro, 1999). A wide range of products 
have been evaluated for decontamination of surfaces (Capoun, 2014; Yang, 1992); however, 
few of these are suitable for skin decontamination (Salerno, 2016; Schwartz, 2012; Thors, 
2017), especially if the skin is damaged (Dalton, 2017; Lydon, 2017). Given the lack of 
medical treatments for some chemical contaminants, such as sulphur mustard, 
decontamination can be used to mitigate toxic effects by reducing the contaminant and 
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removing it from skin, thus preventing or at least ameliorating the subsequent lesion severity 
(Chilcott, 2007; Hall, 2017). 
The objective of this current study was to extend the evaluation of five candidate 
products identified from a previous study (Matar, 2016) for the decontamination of chemical 
warfare agents. The rationale behind this work was to discover alternative products that could  
be used at the scene of an incident, prior to the deployment of specialised services, in 
conjunction with or in lieu of showering. A recent study demonstrated the effectiveness of 
using any absorptive material for decontamination (Kassouf, 2017). However, the ability to 
retain these contaminants should be evaluated to prevent secondary contamination. 
2. Materials and Methods 
2.1. Chemicals 
The storage and use of chemical warfare agents (CWA) was performed in full 
compliance with the chemical weapons conventions. CWA soman (GD), sulphur mustard 
(HD), VX and their (14C) radiolabelled analogues were custom synthesised by TNO Defense, 
Security and Safety (Rijswijk, Netherlands) and were reported to be >97% pure. 
Radiolabelled 14C-Soman (23.5 mCi mmol-1), 14C-sulphur mustard (56 mCi mmol-1) and 14C-
VX (31 mCi mmol-1) were mixed with their corresponding unlabelled analogues to provide a 
stock solution with a nominal activity of ~1 mCi  g-1 that was stored for up to six months at 
4°C. Aliquots of each stock solution were diluted with their respective unlabelled CW agent 
immediately prior to each experiment to provide a working solution with a nominal activity 
of ~0.5 µCi µL-1. 
Soluene®-350 and Ultima Gold™ liquid scintillation counting (LSC) fluid were 
purchased from PerkinElmer, Cambridgeshire, UK. Propan-2-ol and ethanol were obtained 
from Fisher Scientific, Leicestershire, UK. 
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Proprietary products obtained for evaluation were fuller’s earth (FE) (Sigma Aldrich, 
Poole, UK) and the Fast-Act® chemical containment and neutralisation system (NanoScale, 
Manhattan, USA). Novel polymers itaconic acid (IA), N,N ′-methylenebisacrylamide (MBA) 
and 2-trifluoromethylacrylic acid (TFMAA) were prepared by the University of Cranfield 
(Cranfield, UK) as described in the patent (Chilcott, 2013). 
2.2. Skin Samples 
Full-thickness skin was obtained post mortem from female pigs (Sus scrofa, large white 
strain, weight range 15-25 kg) purchased from a reputable supplier. The skin was close 
clipped and excised from the dorsal aspect (full thickness) from each animal. The skin was 
then wrapped in aluminium foil and stored flat at -20°C for up to 3 months before use. Prior 
to the commencement of each experiment, a skin sample from a single animal was removed 
from cold storage and thawed in a refrigerator (4ºC) for approximately 24 hours. The skin 
was then dermatomed to a nominal depth of 500 μm using a Humeca Model D42, 
(Eurosurgical Ltd., Guildford, UK) and the thickness of the resulting skin section confirmed 
using a digital micrometer gauge (Tooled-Up, Middlesex, UK). Once dermatomed, the skin 
was cut into squares (3 × 3 cm) in preparation for mounting on to diffusion cells. 
2.3. Diffusion Cells 
Static skin diffusion cells were purchased from PermeGear (Chicago, Illinois, USA) and 
were based upon the design of the Franz diffusion cell (Franz, 1975). Each diffusion cell 
comprises an upper (donor) and lower (receptor) chamber, with an area available for 
diffusion of 1.76 cm2. Dermatomed skin sections were placed between the two chambers, 
with the epidermal surface facing the donor chamber, and the ensemble was securely 
clamped. The receptor chambers were filled with 50% (v/v) aqueous ethanol (14 ± 0.8 mL). 
Each diffusion cell was placed in a Perspex™ holder above a magnetic stirrer which 
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constantly mixed the receptor fluid via a (12 × 6 mm) Teflon™-coated iron bar placed within 
the receptor chamber. The receptor chambers were equipped with a jacket, through which 
warm (36ºC) water was pumped from a circulating water heater (Model GD120, Grant 
Instruments, Cambridge, UK) via a manifold to ensure a constant skin surface temperature of 
32ºC, as confirmed by infrared thermography (FLIR Model P620 camera, Cambridge, UK). 
Once assembled, the diffusion cells were left in situ for an equilibration period of up to 24 
hours. 
Thirty-six diffusion cells were used in each experiment, divided into six treatment groups 
each comprising n=6 diffusion cells. 
2.4. Experimental Procedure 
Each experiment was initiated by the addition of either 10 μL 14C-radiolabelled soman 
(GD), sulphur mustard (HD) or VX (0.5 μCi μL-1) to the skin surface of each diffusion cell. 
Samples of receptor fluid (250 μL) were withdrawn from each diffusion cell at 3-hour 
intervals up to 24 h post exposure and were placed into vials containing 5 mL of LSC fluid. 
Each receptor chamber was replenished with an equivalent volume (250 μL) of fresh fluid to 
maintain a constant volume in the receptor chamber. 
Decontamination was conducted 5 minutes post exposure by the addition of 200 mg test 
product to each contaminated skin surface (where appropriate). Each product remained in situ 
for 24 hours, at which point they were removed and placed into 20 mL glass vials containing 
20 mL LSC fluid. The contents of each receptor chamber were also removed and placed into 
20 mL glass vials. Each skin surface was then swabbed with a dry gauze pad that was 
subsequently placed in 20 mL isopropanol. Finally, the skin samples from all diffusion cells 
were removed and placed into pre-weighed vials. The difference between the weight of each 
vial before and after addition of each skin sample allowed a calculation of the skin weight. 
Each skin sample was then dissolved in 10 mL of Soluene-350. 
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All vials were stored at room temperature (with occasional shaking) for up to 5 days, 
after which aliquots (250 μL) were removed and placed into vials containing 5 mL LSC fluid. 
Standard solutions were prepared on the day of each experiment by the addition of 2 μL 14C-
radiolabelled soman, sulphur mustard or VX to (a) known weights of fresh test products in 20 
mL LSC fluid or 20 mL isopropanol, (b) unused gauze pads in 20 mL isopropanol and (c) 
unexposed skin tissue dissolved in 10 mL Soluene-350. Each of the standard solutions was 
prepared in triplicate and was then subject to an identical sampling regime, in which 250 μL 
aliquots were placed into vials containing 5 mL LSC fluid. A standard receptor chamber 
solution was also prepared in triplicate by the addition of 10 μL of 14C-GD, HD or VX to 990 
μL of fresh receptor fluid (50% aqueous ethanol), from which a range of triplicate samples 
(25, 50, 75 and 100 μL) were placed into vials containing 5 mL of LSC fluid to produce a 
standard (calibration) curve. Aliquots (250 μL) of each the samples (i.e. skin, receptor fluid, 
swabs, and decontaminants) were placed into vials containing 5 mL of LSC fluid prior to 
measurements. 
2.5. Liquid Scintillation Counting 
The radioactivity in each sample was quantified using a PerkinElmer Tri-Carb liquid 
scintillation counter (Model 2810 TR), employing an analysis runtime of 2 minutes per 
sample and a pre-set quench curve specific to the brand of LSC fluid (Ultima Gold™). The 
amounts of radioactivity in each sample were converted to quantities of 14C-radiolabelled 
chemical warfare agent by comparison with the corresponding standards (measured 
simultaneously). Quantification of the amounts of CWA recovered in each receptor chamber 
enabled a calculation of the cumulative dermal absorption over 24 hours. These were 
averaged at each time point for each treatment group and plotted as total amount penetrated 
(μg cm-2) against time for each experiment. 
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2.6. Data Analysis 
In order to permit an inter-experimental comparison of the performance of each 
treatment, the data were normalised relative to controls within each experiment using 
Equation 1: 
 %CD24 = (QT24/QC24) × 100 Eq. (1) 
where %CD24 is the percentage of the control dose penetrating the skin, QT24 is the quantity 
of contaminant penetrating the skin at 24 hours following treatment (decontamination) and 
QC24 is the quantity of contaminant penetrating control (untreated) skin at 24 hours. 
The maximum rate of penetration (Jmax) was calculated from the amount penetrated 
against time, which was averaged across the number of replicates. The time at which Jmax was 
achieved (Tmax) was also averaged across all cells. 
2.7. Statistical Analysis 
A test for normality (Kolmogorov–Smirnov) was conducted on all data (per group) 
acquired from the in vitro studies: the data were found to be not normally distributed (non-
Gaussian) and so were analysed using non-parametric statistical tests. Treatment effects were 
analysed using the non-parametric equivalent of one-way analysis of variance (ANOVA; 
Kruskal-Wallis) followed by Dunn’s post-test, allowing comparisons of each group against a 
control group. A probability level of p < 0.05 was the criterion for statistical significance 
throughout. 
3. Results 
All of the products evaluated (IA, TFMAA, MBA, FE and Fast-Act®) reduced the 
penetration of 14C-GD, HD and VX compared to their respective controls (Figure 1). With 
respect to 14C-GD penetration, FE, IA and TFMAA achieved a significant (p < 0.05) 
reduction compared to controls at 24 hours. FE, TFMAA, IA and Fast-Act® all significantly 
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decreased the amount of 14C-HD compared to controls at 24 hours (p < 0.05). The same was 
true for 14C-VX (Figure 1). 
Similarly, all treatments greatly reduced the flux over 24 hours (Figure 2). TFMAA, IA 
and FE were the only three products to significantly (p < 0.05) reduce Jmax of 
14C-GD. 
Additionally, TFMAA, FE and FA significantly reduced J max of 
14C-HD, whilst FE, FA and 
IA significantly reduced Jmax of 
14C-VX over 24 hours. 
No significant effects on Tmax were observed for any of the products with respect to 
14C-
GD (Figure 2, A). All of the products employed against 14C-HD significantly (p < 0.05) 
reduced Tmax, whilst IA, FE and MBA significantly reduced Tmax with respect to 
14C-VX 
(Figure 2, B & C). 
Among the three contaminants, there was a large variation in the percentage dose 
recovered, with the least recovery from HD (2%) and the greatest from VX (70%) (Tables 1-
4). All of the decontaminants applied to the skin 5 minutes post exposure achieved a marked 
reduction in the amount of 14C contaminant remaining within the skin at 24 hours. IA 
significantly (p < 0.05) reduced the amount of 14C-HD, GD and VX remaining in the skin at 
24 hours (Table 1). Additionally, TFMAA significantly reduced the amount of 14C-HD, 
whilst FE and FA significantly reduced the amounts of 14C-HD and VX recovered within the 
skin at 24 hours (Table 1). 
The amounts remaining on the skin surface at 24 hours were not significantly reduced by 
any of the decontaminants when compared to their respective controls (Table 2). TFMAA, 
MBA and FA resulted in increased amounts of 14C-GD remaining on the skin surface 
compared to controls, though the differences were not statistically significant. 
There was no statistical difference between the amounts of 14C-GD, HD or VX retained 
by each of the tested products when compared to FE (Table 3). 
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4. Discussion 
Based upon the penetration profiles for each experiment in this study, it was difficult to 
discriminate between the products in terms of amount and rate of penetration of CWA. 
However, some differences were apparent among the five remaining products: MBA did not 
significantly reduce Jmax or overall absorbed dose compared to any of the agents, and neither 
TFMAA nor Fast-Act® performed as well as FE or IA against 14C-GD. Thus, the products 
that showed all round efficacy against all three CWA (soman, sulphur mustard and VX) and 
methyl salicylate (Matar, 2016) in terms of reduced J max and total amount penetrated were IA, 
FE, and TFMAA. 
The main mechanism of action for the test products is absorption, with the exception of 
Fast-Act®, which combines absorption with the capability to neutralise chemical warfare 
agents via hydrolysis and or dehydrohalogenation (Lanz and Allen, 2004). The molecularly 
imprinted polymers were designed to bind a range of chemicals with a relatively high 
affinity. However, further work is required to characterise any additional abilities, such as 
neutralisation. 
One of the advantages of identifying an effective synthetic product is the ability to 
molecularly imprint these polymers into sponges or textiles. In recent years, there has been 
some scepticism over the suitability of aqueous-based decontamination systems, due to the 
phenomenon of a “wash-in” effect that can enhance chemical penetration through the skin 
(Idson, 1978; Moody and Nadeau, 1997; Zhai, 2002). Studies comparing the effectiveness of 
washing the skin or using absorbent materials resulted in better efficacy when absorbent 
materials were employed (Amlôt, 2017; Kassouf, 2017; Lademann, 2011). A further reason 
for developing a sponge or textile formulation is to mitigate possible issues surrounding the 
use of powder decontaminants, such as methods of application to the skin, containment and 
clear-up, in light of the dispersive properties of powders as well as their potential to be 
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inhaled (Waysbort, 2009). Furthermore, sponges may be more suitable for applications where 
the skin barrier is damaged or there are penetrating wounds, as studies have shown that 
reactive skin decontamination lotion is contraindicated for use on damaged skin (Walters, 
2007), while granular products such as fuller’s earth are unsuitable for intra-wound use 
because of the risk of an inflammatory response and neurovascular injury (Gerlach, 2010). 
The methodology employed in this study requires some consideration. Although it is 
highly unlikely that a decontamination product could be administered 5 minutes post 
exposure in a mass-casualty incident, the authors wished to observe the efficacy of the 
decontamination agents under optimum conditions. In addition, the products were left on the 
skin surface for a relatively long duration (24 hours), in order to further evaluate their ability 
to retain the contaminant. Off-gassing and secondary hazards are serious issues in this type of 
CWA scenario, posing a potential risk to emergency workers and the general public after 
such events as the sarin attacks in the Tokyo subway, as well as the possible contamination of 
hospital staff who have to treat victims (Okumura, 1996). A further limitation of this study 
was the use of radiolabelled chemicals without further chemical analysis to assess whether 
the agents were intact or a neutralised by-product. However, this represents a highly 
conservative approach to determining decontamination efficiency, as all measured 
radioactivity was assumed to be representative of the original toxic agent, rather than of any 
less toxic breakdown products. 
5. Conclusions 
All of the products evaluated in this study performed well in reducing the dermal 
absorption of all three chemical warfare agents. Further studies will evaluate more realistic 
exposure scenarios and decontamination efficacy investigated up to 6 hours post exposure, 
progressing to in vivo and human volunteer trials. 
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surface. Skin surface decontamination was conducted five minutes post exposure 
using itaconic acid (IA), fuller’s earth (FE), Fast-Act®, N,N′-methylenebisacrylamide 
(MBA) and 2-trifluoromethylacrylic acid (TFMAA). Asterisk (*) indicates significant 
(p < 0.05) reductions in amount penetrated at 24 hours compared to control. All points 
are mean ± standard deviation of n=6 diffusion cells. Porcine skin was obtained from 
the dorsum of a single animal. 
Fig. 2. Flux profile of 14C-Radiolabelled soman (GD, A), sulphur mustard (HD, B) and VX 
(C) penetrating untreated (control) or decontaminated pig skin over a 24 hour period. 10 µL 
of 14C-GD, HD or VX (5 µCi total per cell) was applied to the skin surface. Skin surface 
decontamination was conducted five minutes post exposure using itaconic acid (IA), fuller’s 
earth (FE), Fast-Act®, N,N′-methylenebisacrylamide (MBA) and 2-trifluoromethylacrylic 
acid (TFMAA). Asterisk (*) indicates significant (p < 0.05) reductions in Jmax compared to 
control. Hash (#) indicates significant (p < 0.05) reductions in Tmax compared to control. All 
points are mean ± standard deviation of n=6 diffusion cells. Porcine skin was obtained from 
the dorsum of a single animal. 
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Table 1. Dose distribution as a percentage of the applied dose of 14C-radiolabelled soman 
(GD), sulphur mustard (HD) or VX penetrating untreated (control) or decontaminated pig 
skin over a 24 hour period. 
Amount (% of applied dose) absorbed in the skin 
 GD HD VX 
Control 9.1 ± 1.7 1.0 ± 0.1 65.1 ± 2.8 
IA 0.4 ± 0.6* 0.2 ± 0.1* 3.6 ± 1.5* 
TFMAA 6.6 ± 3.9 0.1 ± 0.0* 7.5 ± 2.7 
MBA 4.0 ± 5.2 0.6 ± 1.0 6.3 ± 5.0 
Fast-Act® 4.4 ± 2.7 0.2 ± 0.1* 6.3 ± 4.1* 
Fuller’s earth 2.1 ± 2.5 0.2 ± 0.0* 3.7 ± 7.1* 
Skin surface decontamination was conducted five minutes post exposure using itaconic acid (IA), 2 -
trifluoromethylacrylic acid (TFMAA), N,N-methylenebisacrylamide (MBA), Fast-Act® and fuller’s earth. All 
values are mean ± standard deviation of n=6 diffusion cells. Porcine skin was obtained from the dorsum of a 
single animal. Asterisk symbol (*) indicates significant reductions (p < 0.05) in the amount of 
14
C-GD, HD or 
VX remaining within the skin at 24 hours compared to control. 
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Table 2. Dose distribution as a percentage of the applied dose of 14C-radiolabelled soman 
(GD), sulphur mustard (HD) or VX remaining on the skin surface of untreated (control) or 
decontaminated pig skin over a 24 hour period. 
Amount (% of applied dose) recovered on the skin surface 
 GD HD VX 
Control 0.9 ± 0.5 0.1 ± 0.0 0.5 ± 0.3 
IA 0.1 ± 0.1 0.2 ± 0.1 0.3 ± 0.2 
TFMAA 1.6 ± 0.1 0.2 ± 0.0 0.5 ± 0.2 
MBA 4.6 ± 2.0 0.2 ± 0.1 0.3 ± 0.5 
Fast-Act 1.7 ± 1.1 0.1 ± 0.1 1.5 ± 0.1 
Fuller’s earth 0.1 ± 0.5 0.1 ± 0.0 0.3 ± 0.2 
Skin surface decontamination was conducted five minutes post exposure using itaconic acid (IA), 2 -
trifluoromethylacrylic acid (TFMAA), N,N′-methylenebisacrylamide (MBA), Fast-Act® and fuller’s earth. All 
values are mean ± standard deviation of n=6 diffusion cells. Porcine skin was obtained from the dorsum of a 
single animal. 
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Table 3. Dose distribution as a percentage of the applied dose of 14C-radiolabelled soman 
(GD), sulphur mustard (HD) or VX retained within the decontaminants over a 24 hour period. 
Amount (% of applied dose) retained within the decontaminants 
 GD HD VX 
Control N/A N/A N/A 
IA 83.0 ± 10.9 84.9 ± 20.8 51.2 ± 21.5 
TFMAA 1.8 ± 11.6 91.3 ± 34.5 50.1 ± 11.0 
MBA 22.7 ± 35.2 25.2 ± 38.7 56.7 ± 28.5 
Fast-Act® 68.6 ± 23.5 45.9 ± 24.6 24.6 ± 19.2 
Fuller’s earth 28.0 ± 1.6 69.5 ± 28.1 29.0 ± 12.9 
Skin surface decontamination was conducted five minutes post exposure using itaconic acid (IA), 2-
trifluoromethylacrylic acid (TFMAA), N,N′-methylenebisacrylamide (MBA), Fast-Act® and fuller’s earth. All 
values are mean ± standard deviation of n=6 diffusion cells. Porcine skin was obtained from the dorsum of a 
single animal. 
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Highlights: 
 
 Five decontaminants were tested against chemical warfare agents applied to porcine skin. 
 All achieved a marked reduction in the amount of contaminant within the skin. 
 Early deployment of countermeasures may help mitigate skin absorption. 
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